Surface-enhanced laser desorption ionization/time-of-flight mass spectrometry reveals significant artifacts in serum obtained from clot activator-containing collection devices.
Pilny R, Bouchal P, Borilova S, Ceskova P, Zaloudik J, Vyzula R, Vojtesek B, Valik D
Purpose
Conclusion
Studies (1)
Purpose
The purpose of this study was to determine the effects of collecting blood in clot activator-containing tubes and frozen storage of serum on proteomic analysis. All serum was stored in aliquots at -25 degrees C prior to analysis. A second set of 10 aliquots was analyzed 2 months after the first set.
Summary of Findings
MS spectra of specimens collected in tubes containing clot activator had two peaks with >40-fold higher peak intensities than those seen for specimens collected in tubes without clot activator. Further, these two peaks were next to two other peaks which were decreased in some spectra from specimens collected in tubes with clot activator. No changes in spectra occurred during two months of additional frozen storage.
Biospecimens
FluidSerumFluidBloodPreservation Types
FrozenDiagnoses
NormalPlatforms
PeptideSELDI-TOF MSProteinSELDI-TOF MSPre-analytical Factors
Classification Pre-Analytical Factor Value(s) Biospecimen Acquisition Type of collection container/solution Microvette Sarstedt Serum Gel Clotting activator tubesMicrovette Sarstedt tubesStorage Storage duration UnspecifiedUnspecified + 2 months